Guangdong VTR Bio-Tech Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Public

  • Employees
  • 1,106

Employees

  • Stock Symbol
  • 300381

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $0.79
  • (As of Friday Closing)

Guangdong VTR Bio-Tech General Information

Description

Guangdong VTR Bio-Tech Co Ltd is a China based biotechnology company. It is engaged in the research, development, production, sales and service of biopharmaceuticals, bio-enzyme preparations, microbial preparations, functional additives and green biological manufacturing engineering. The company's products include Wittler tributyrin, temperature glucose oxidase, Mildew, VTR-TH26 glucoamylase, Sorghum specific compound enzyme and others. It sells its products in China, and also exports it to various other countries.

Contact Information

Website
www.yiduoli.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • No. 8 Pingbei Road 1
  • Science and Technology Industry Zone Nanping
  • Zhuhai, Guangdong 519060
  • China
+86 175
Primary Industry
Biotechnology
Other Industries
Animal Husbandry
Stock Exchange
SHE
Corporate Office
  • No. 8 Pingbei Road 1
  • Science and Technology Industry Zone Nanping
  • Zhuhai, Guangdong 519060
  • China
+86 175

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Guangdong VTR Bio-Tech Stock Performance

As of 13-Nov-2026, Guangdong VTR Bio-Tech’s stock price is $0.79. Its current market cap is $377M with 480M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.79 $0.80 $0.74 - $1.13 $377M 480M 9.6M -$0.01

Guangdong VTR Bio-Tech Financials Summary

As of 30-Sep-2026, Guangdong VTR Bio-Tech has a trailing 12-month revenue of $120M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 348,482 381,000 367,345 360,161
Revenue 119,990 115,731 115,143 112,514
EBITDA (5,613) 14,030 19,358 12,481
Net Income (4,974) (2,750) 4,333 (1,519)
Total Assets 420,619 418,046 403,911 436,607
Total Debt 7,558 8,878 4,811 18,092
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Guangdong VTR Bio-Tech Patents

Guangdong VTR Bio-Tech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026158348-A1 Nuclease mutant and use thereof Pending 22-Jan-2025
WO-2026112760-A1 Glucose oxidase mutant, preparation method therefor, and use thereof Pending 26-Nov-2024
WO-2026091089-A1 Acid protease mutant, encoding gene therefor, and use thereof Pending 01-Nov-2024
WO-2026060548-A1 Heat-resistant glucose oxidase mutant, preparation method therefor and use thereof Pending 18-Sep-2024
WO-2026044477-A1 Alkaline protease mutant and use thereof Pending 27-Aug-2024
To view Guangdong VTR Bio-Tech’s complete patent history, request access »

Guangdong VTR Bio-Tech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Guangdong VTR Bio-Tech Investments & Acquisitions (5)

Guangdong VTR Bio-Tech’s most recent deal was a Secondary Transaction - Private with Mekeda Bio-resources for . The deal was made on 05-Jan-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Mekeda Bio-resources 05-Jan-2024 Secondary Transaction - Private Other Agriculture
KYF (Pharmaceuticals) 20-Sep-2019 Secondary Transaction - Private Pharmaceuticals
KYF (Pharmaceuticals) 10-Dec-2015 Merger/Acquisition Pharmaceuticals
Henan Lihua Pharmaceutical 05-Aug-2015 Merger/Acquisition Pharmaceuticals
Hunan Hongying Biotechnology 29-Dec-2014 Merger/Acquisition Multi-line Chemicals
To view Guangdong VTR Bio-Tech’s complete investments and acquisitions history, request access »

Guangdong VTR Bio-Tech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Guangdong VTR Bio-Tech’s complete esg history, request access »

Guangdong VTR Bio-Tech Exits (3)

Guangdong VTR Bio-Tech’s most recent exit was on 20-Sep-2019 from KYF (Pharmaceuticals). The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
KYF (Pharmaceuticals) 20-Sep-2019 Completed
KYF (Pharmaceuticals) 10-Dec-2015 Completed
Henan Lihua Pharmaceutical 05-Aug-2015 Merger/Acquisition Completed
To view Guangdong VTR Bio-Tech’s complete exits history, request access »

Guangdong VTR Bio-Tech Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Mekeda Bio-resources Liuyang, China 2006

Guangdong VTR Bio-Tech FAQs

  • When was Guangdong VTR Bio-Tech founded?

    Guangdong VTR Bio-Tech was founded in 1991.

  • Where is Guangdong VTR Bio-Tech headquartered?

    Guangdong VTR Bio-Tech is headquartered in Zhuhai, China.

  • What is the size of Guangdong VTR Bio-Tech?

    Guangdong VTR Bio-Tech has 1,106 total employees.

  • What industry is Guangdong VTR Bio-Tech in?

    Guangdong VTR Bio-Tech’s primary industry is Biotechnology.

  • Is Guangdong VTR Bio-Tech a private or public company?

    Guangdong VTR Bio-Tech is a Public company.

  • What is Guangdong VTR Bio-Tech’s stock symbol?

    The ticker symbol for Guangdong VTR Bio-Tech is 300381.

  • What is the current stock price of Guangdong VTR Bio-Tech?

    As of 13-Nov-2026 the stock price of Guangdong VTR Bio-Tech is $0.79.

  • What is the current market cap of Guangdong VTR Bio-Tech?

    The current market capitalization of Guangdong VTR Bio-Tech is $377M.

  • What is Guangdong VTR Bio-Tech’s current revenue?

    The trailing twelve month revenue for Guangdong VTR Bio-Tech is $120M.

  • What is Guangdong VTR Bio-Tech’s annual earnings per share (EPS)?

    Guangdong VTR Bio-Tech’s EPS for 12 months was -$0.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process